nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrosine—TH—Nicotine Activity on Dopaminergic Neurons—CHRNA5—lung cancer	0.0309	0.0612	CbGpPWpGaD
Metyrosine—Hypervigilance—Methotrexate—lung cancer	0.0295	0.0629	CcSEcCtD
Metyrosine—TH—Alpha-synuclein signaling—UCHL1—lung cancer	0.0273	0.0541	CbGpPWpGaD
Metyrosine—TH—Nicotine Activity on Dopaminergic Neurons—CHRNA3—lung cancer	0.0252	0.0499	CbGpPWpGaD
Metyrosine—TH—Dopamine metabolism—NQO1—lung cancer	0.0249	0.0492	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—UCHL1—lung cancer	0.0232	0.046	CbGpPWpGaD
Metyrosine—TH—p38 signaling mediated by MAPKAP kinases—SFN—lung cancer	0.0227	0.0449	CbGpPWpGaD
Metyrosine—TH—p38 signaling mediated by MAPKAP kinases—HSPB1—lung cancer	0.0201	0.0399	CbGpPWpGaD
Metyrosine—TH—Alpha-synuclein signaling—FGR—lung cancer	0.0185	0.0365	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—SOX2—lung cancer	0.0176	0.0349	CbGpPWpGaD
Metyrosine—Salivation—Irinotecan—lung cancer	0.011	0.0235	CcSEcCtD
Metyrosine—TH—Amino acid and derivative metabolism—AZIN2—lung cancer	0.011	0.0217	CbGpPWpGaD
Metyrosine—Speech impairment NOS—Methotrexate—lung cancer	0.00973	0.0208	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—ATF3—lung cancer	0.00971	0.0192	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—NPPA—lung cancer	0.00894	0.0177	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—ATF3—lung cancer	0.00847	0.0168	CbGpPWpGaD
Metyrosine—TH—Amino acid and derivative metabolism—HSD17B10—lung cancer	0.0076	0.015	CbGpPWpGaD
Metyrosine—TH—p38 signaling mediated by MAPKAP kinases—RAF1—lung cancer	0.00756	0.015	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—JUNB—lung cancer	0.00736	0.0146	CbGpPWpGaD
Metyrosine—Aspartate aminotransferase increased—Crizotinib—lung cancer	0.0072	0.0154	CcSEcCtD
Metyrosine—TH—Amino acid and derivative metabolism—CKB—lung cancer	0.00706	0.014	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—KMT2A—lung cancer	0.00669	0.0133	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00668	0.0132	CbGpPWpGaD
Metyrosine—Thrombocytosis—Gemcitabine—lung cancer	0.00668	0.0142	CcSEcCtD
Metyrosine—TH—Amino acid and derivative metabolism—CNDP2—lung cancer	0.00664	0.0132	CbGpPWpGaD
Metyrosine—Aspartate aminotransferase increased—Pemetrexed—lung cancer	0.00658	0.014	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Gefitinib—lung cancer	0.00654	0.0139	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—JUNB—lung cancer	0.00642	0.0127	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—TOP1—lung cancer	0.00612	0.0121	CbGpPWpGaD
Metyrosine—TH—Circadian rythm related genes—NKX2-1—lung cancer	0.00597	0.0118	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—HES1—lung cancer	0.00571	0.0113	CbGpPWpGaD
Metyrosine—Acetaminophen—UGT1A1—lung cancer	0.0057	0.216	CrCbGaD
Metyrosine—Oedema peripheral—Crizotinib—lung cancer	0.00545	0.0116	CcSEcCtD
Metyrosine—Haematuria—Gefitinib—lung cancer	0.00533	0.0114	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.00507	0.01	CbGpPWpGaD
Metyrosine—Speech disorder—Irinotecan—lung cancer	0.00496	0.0106	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—IL10—lung cancer	0.00495	0.00981	CbGpPWpGaD
Metyrosine—Oedema peripheral—Gefitinib—lung cancer	0.00495	0.0106	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—BCL2L1—lung cancer	0.00481	0.00952	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—SOX2—lung cancer	0.00471	0.00933	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.00456	0.00903	CbGpPWpGaD
Metyrosine—Anaemia—Crizotinib—lung cancer	0.00445	0.00949	CcSEcCtD
Metyrosine—TH—Alpha-synuclein signaling—SRC—lung cancer	0.00433	0.00858	CbGpPWpGaD
Metyrosine—TH—Dopaminergic Neurogenesis—STAT3—lung cancer	0.00429	0.0085	CbGpPWpGaD
Metyrosine—TH—Parkinsons Disease Pathway—CASP3—lung cancer	0.00423	0.00837	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—MMP1—lung cancer	0.00421	0.00834	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—HIF1A—lung cancer	0.00418	0.00827	CbGpPWpGaD
Metyrosine—Blood disorder—Paclitaxel—lung cancer	0.00416	0.00888	CcSEcCtD
Metyrosine—Salivary hypersecretion—Irinotecan—lung cancer	0.00414	0.00883	CcSEcCtD
Metyrosine—Anaemia—Pemetrexed—lung cancer	0.00407	0.00867	CcSEcCtD
Metyrosine—Anaemia—Gefitinib—lung cancer	0.00404	0.00862	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—TF—lung cancer	0.004	0.00793	CbGpPWpGaD
Metyrosine—Aspartate aminotransferase increased—Topotecan—lung cancer	0.00395	0.00842	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—AHR—lung cancer	0.00395	0.00781	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—RB1—lung cancer	0.0039	0.00772	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—MMP2—lung cancer	0.00374	0.0074	CbGpPWpGaD
Metyrosine—Dry mouth—Gefitinib—lung cancer	0.00364	0.00776	CcSEcCtD
Metyrosine—Acetaminophen—CYP2A6—lung cancer	0.00358	0.136	CrCbGaD
Metyrosine—TH—Circadian rythm related genes—ADCY1—lung cancer	0.00352	0.00697	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Pemetrexed—lung cancer	0.00352	0.0075	CcSEcCtD
Metyrosine—Thrombocytopenia—Gefitinib—lung cancer	0.00349	0.00745	CcSEcCtD
Metyrosine—TH—Amino acid and derivative metabolism—GCLC—lung cancer	0.00349	0.00691	CbGpPWpGaD
Metyrosine—Fatigue—Crizotinib—lung cancer	0.00339	0.00723	CcSEcCtD
Metyrosine—Ibuprofen—UGT1A1—lung cancer	0.00339	0.128	CrCbGaD
Metyrosine—Aspartate aminotransferase increased—Vinorelbine—lung cancer	0.00338	0.00721	CcSEcCtD
Metyrosine—Anaemia—Teniposide—lung cancer	0.00329	0.00703	CcSEcCtD
Metyrosine—Ibuprofen—CXCL8—lung cancer	0.00319	0.121	CrCbGaD
Metyrosine—TH—ATF-2 transcription factor network—CXCL8—lung cancer	0.00311	0.00615	CbGpPWpGaD
Metyrosine—Fatigue—Pemetrexed—lung cancer	0.0031	0.0066	CcSEcCtD
Metyrosine—Nasal congestion—Cisplatin—lung cancer	0.00308	0.00658	CcSEcCtD
Metyrosine—Fatigue—Gefitinib—lung cancer	0.00308	0.00656	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CDKN2A—lung cancer	0.00299	0.00592	CbGpPWpGaD
Metyrosine—Thrombocytosis—Doxorubicin—lung cancer	0.00296	0.00631	CcSEcCtD
Metyrosine—Gastrointestinal pain—Pemetrexed—lung cancer	0.00294	0.00626	CcSEcCtD
Metyrosine—TH—Amino acid and derivative metabolism—NQO1—lung cancer	0.00293	0.00581	CbGpPWpGaD
Metyrosine—Confusional state—Teniposide—lung cancer	0.00293	0.00626	CcSEcCtD
Metyrosine—Swelling—Etoposide—lung cancer	0.00292	0.00622	CcSEcCtD
Metyrosine—Gastrointestinal pain—Gefitinib—lung cancer	0.00292	0.00622	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—CCND1—lung cancer	0.00289	0.00573	CbGpPWpGaD
Metyrosine—TH—ATF-2 transcription factor network—JUN—lung cancer	0.00289	0.00572	CbGpPWpGaD
Metyrosine—Swelling—Paclitaxel—lung cancer	0.00286	0.0061	CcSEcCtD
Metyrosine—Urticaria—Pemetrexed—lung cancer	0.00285	0.00608	CcSEcCtD
Metyrosine—Thrombocytopenia—Teniposide—lung cancer	0.00285	0.00607	CcSEcCtD
Metyrosine—Abdominal pain—Pemetrexed—lung cancer	0.00284	0.00605	CcSEcCtD
Metyrosine—Urticaria—Gefitinib—lung cancer	0.00283	0.00605	CcSEcCtD
Metyrosine—Abdominal pain—Gefitinib—lung cancer	0.00282	0.00602	CcSEcCtD
Metyrosine—Asthenia—Crizotinib—lung cancer	0.00282	0.00601	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Irinotecan—lung cancer	0.00279	0.00594	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—AVP—lung cancer	0.00278	0.0055	CbGpPWpGaD
Metyrosine—Nasal congestion—Paclitaxel—lung cancer	0.00277	0.00591	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Gemcitabine—lung cancer	0.00271	0.00579	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CXCL8—lung cancer	0.00271	0.00537	CbGpPWpGaD
Metyrosine—Diarrhoea—Crizotinib—lung cancer	0.00269	0.00573	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—EP300—lung cancer	0.00266	0.00528	CbGpPWpGaD
Metyrosine—Hypersensitivity—Pemetrexed—lung cancer	0.00265	0.00564	CcSEcCtD
Metyrosine—Hypersensitivity—Gefitinib—lung cancer	0.00263	0.00561	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—HES1—lung cancer	0.00262	0.0052	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—IL10—lung cancer	0.00261	0.00517	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—IL2—lung cancer	0.00259	0.00513	CbGpPWpGaD
Metyrosine—Asthenia—Pemetrexed—lung cancer	0.00258	0.0055	CcSEcCtD
Metyrosine—Asthenia—Gefitinib—lung cancer	0.00256	0.00546	CcSEcCtD
Metyrosine—Acetaminophen—CYP2E1—lung cancer	0.00254	0.0964	CrCbGaD
Metyrosine—Aspartate aminotransferase increased—Cisplatin—lung cancer	0.00253	0.0054	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—CCND1—lung cancer	0.00252	0.005	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—JUN—lung cancer	0.00252	0.00499	CbGpPWpGaD
Metyrosine—Anaemia—Vinblastine—lung cancer	0.00251	0.00536	CcSEcCtD
Metyrosine—Acetaminophen—CYP1A1—lung cancer	0.00251	0.0951	CrCbGaD
Metyrosine—Vomiting—Crizotinib—lung cancer	0.0025	0.00533	CcSEcCtD
Metyrosine—Speech disorder—Methotrexate—lung cancer	0.00247	0.00527	CcSEcCtD
Metyrosine—Diarrhoea—Pemetrexed—lung cancer	0.00246	0.00524	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MMP9—lung cancer	0.00245	0.00485	CbGpPWpGaD
Metyrosine—Anaemia—Topotecan—lung cancer	0.00244	0.00521	CcSEcCtD
Metyrosine—Diarrhoea—Gefitinib—lung cancer	0.00244	0.00521	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—PTEN—lung cancer	0.00244	0.00482	CbGpPWpGaD
Metyrosine—Swelling—Docetaxel—lung cancer	0.00242	0.00517	CcSEcCtD
Metyrosine—Feeling abnormal—Teniposide—lung cancer	0.0024	0.00511	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—MAPK3—lung cancer	0.00239	0.00473	CbGpPWpGaD
Metyrosine—Gastrointestinal pain—Teniposide—lung cancer	0.00238	0.00507	CcSEcCtD
Metyrosine—Nausea—Crizotinib—lung cancer	0.00233	0.00498	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—EP300—lung cancer	0.00232	0.0046	CbGpPWpGaD
Metyrosine—Urticaria—Teniposide—lung cancer	0.00231	0.00493	CcSEcCtD
Metyrosine—Abdominal pain—Teniposide—lung cancer	0.0023	0.0049	CcSEcCtD
Metyrosine—Vomiting—Pemetrexed—lung cancer	0.00228	0.00487	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Paclitaxel—lung cancer	0.00227	0.00485	CcSEcCtD
Metyrosine—Vomiting—Gefitinib—lung cancer	0.00227	0.00484	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—AVP—lung cancer	0.00227	0.00449	CbGpPWpGaD
Metyrosine—Anxiety—Erlotinib—lung cancer	0.00222	0.00473	CcSEcCtD
Metyrosine—Haematuria—Gemcitabine—lung cancer	0.00221	0.00472	CcSEcCtD
Metyrosine—Blood disorder—Doxorubicin—lung cancer	0.0022	0.0047	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.0022	0.00436	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Vinblastine—lung cancer	0.00217	0.00463	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TYMS—lung cancer	0.00216	0.00427	CbGpPWpGaD
Metyrosine—Hypersensitivity—Teniposide—lung cancer	0.00214	0.00457	CcSEcCtD
Metyrosine—Nausea—Pemetrexed—lung cancer	0.00213	0.00455	CcSEcCtD
Metyrosine—Nausea—Gefitinib—lung cancer	0.00212	0.00452	CcSEcCtD
Metyrosine—Thrombocytopenia—Topotecan—lung cancer	0.00211	0.0045	CcSEcCtD
Metyrosine—Anaemia—Vinorelbine—lung cancer	0.00209	0.00445	CcSEcCtD
Metyrosine—Thrombocytopenia—Erlotinib—lung cancer	0.00209	0.00445	CcSEcCtD
Metyrosine—Asthenia—Teniposide—lung cancer	0.00209	0.00445	CcSEcCtD
Metyrosine—Oedema peripheral—Gemcitabine—lung cancer	0.00205	0.00438	CcSEcCtD
Metyrosine—Dysuria—Paclitaxel—lung cancer	0.00204	0.00435	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—MYC—lung cancer	0.00202	0.00401	CbGpPWpGaD
Metyrosine—TH—Metabolism—COL4A3BP—lung cancer	0.00201	0.00399	CbGpPWpGaD
Metyrosine—TH—Metabolism—AZIN2—lung cancer	0.00201	0.00399	CbGpPWpGaD
Metyrosine—Diarrhoea—Teniposide—lung cancer	0.00199	0.00424	CcSEcCtD
Metyrosine—Insomnia—Erlotinib—lung cancer	0.00193	0.00411	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Docetaxel—lung cancer	0.00193	0.00411	CcSEcCtD
Metyrosine—Fatigue—Topotecan—lung cancer	0.00186	0.00396	CcSEcCtD
Metyrosine—Haematuria—Paclitaxel—lung cancer	0.00185	0.00396	CcSEcCtD
Metyrosine—Vomiting—Teniposide—lung cancer	0.00185	0.00394	CcSEcCtD
Metyrosine—Fatigue—Erlotinib—lung cancer	0.00184	0.00392	CcSEcCtD
Metyrosine—Feeling abnormal—Vinblastine—lung cancer	0.00183	0.0039	CcSEcCtD
Metyrosine—Headache—Teniposide—lung cancer	0.00182	0.00389	CcSEcCtD
Metyrosine—Gastrointestinal pain—Vinblastine—lung cancer	0.00181	0.00387	CcSEcCtD
Metyrosine—Thrombocytopenia—Vinorelbine—lung cancer	0.00181	0.00385	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—IL6R—lung cancer	0.0018	0.00356	CbGpPWpGaD
Metyrosine—TH—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.0018	0.00356	CbGpPWpGaD
Metyrosine—Salivary hypersecretion—Doxorubicin—lung cancer	0.00179	0.00381	CcSEcCtD
Metyrosine—Feeling abnormal—Topotecan—lung cancer	0.00178	0.00379	CcSEcCtD
Metyrosine—Gastrointestinal pain—Topotecan—lung cancer	0.00176	0.00376	CcSEcCtD
Metyrosine—Abdominal pain—Vinblastine—lung cancer	0.00175	0.00374	CcSEcCtD
Metyrosine—TH—ATF-2 transcription factor network—IL6—lung cancer	0.00174	0.00346	CbGpPWpGaD
Metyrosine—Gastrointestinal pain—Erlotinib—lung cancer	0.00174	0.00372	CcSEcCtD
Metyrosine—Nausea—Teniposide—lung cancer	0.00173	0.00369	CcSEcCtD
Metyrosine—Anaemia—Irinotecan—lung cancer	0.00172	0.00367	CcSEcCtD
Metyrosine—Oedema peripheral—Paclitaxel—lung cancer	0.00172	0.00367	CcSEcCtD
Metyrosine—Urticaria—Topotecan—lung cancer	0.00171	0.00365	CcSEcCtD
Metyrosine—TH—Metabolism—ATP5H—lung cancer	0.00171	0.00339	CbGpPWpGaD
Metyrosine—Abdominal pain—Topotecan—lung cancer	0.0017	0.00364	CcSEcCtD
Metyrosine—Abdominal pain—Erlotinib—lung cancer	0.00169	0.0036	CcSEcCtD
Metyrosine—Anaemia—Gemcitabine—lung cancer	0.00168	0.00358	CcSEcCtD
Metyrosine—TH—AP-1 transcription factor network—TP53—lung cancer	0.00166	0.00329	CbGpPWpGaD
Metyrosine—Hypersensitivity—Vinblastine—lung cancer	0.00163	0.00349	CcSEcCtD
Metyrosine—Asthenia—Vinblastine—lung cancer	0.00159	0.0034	CcSEcCtD
Metyrosine—Fatigue—Vinorelbine—lung cancer	0.00159	0.00339	CcSEcCtD
Metyrosine—Hypersensitivity—Topotecan—lung cancer	0.00159	0.00339	CcSEcCtD
Metyrosine—Tremor—Cisplatin—lung cancer	0.00159	0.00338	CcSEcCtD
Metyrosine—Acetaminophen—PTGS2—lung cancer	0.00157	0.0595	CrCbGaD
Metyrosine—Anaemia—Cisplatin—lung cancer	0.00156	0.00334	CcSEcCtD
Metyrosine—Asthenia—Topotecan—lung cancer	0.00155	0.0033	CcSEcCtD
Metyrosine—Confusional state—Irinotecan—lung cancer	0.00153	0.00327	CcSEcCtD
Metyrosine—Asthenia—Erlotinib—lung cancer	0.00153	0.00326	CcSEcCtD
Metyrosine—TH—Metabolism—PLBD1—lung cancer	0.00153	0.00302	CbGpPWpGaD
Metyrosine—TH—AP-1 transcription factor network—IL6—lung cancer	0.00152	0.00301	CbGpPWpGaD
Metyrosine—Feeling abnormal—Vinorelbine—lung cancer	0.00152	0.00324	CcSEcCtD
Metyrosine—Diarrhoea—Vinblastine—lung cancer	0.00152	0.00324	CcSEcCtD
Metyrosine—Gastrointestinal pain—Vinorelbine—lung cancer	0.00151	0.00322	CcSEcCtD
Metyrosine—Thrombocytopenia—Irinotecan—lung cancer	0.00149	0.00318	CcSEcCtD
Metyrosine—Diarrhoea—Topotecan—lung cancer	0.00147	0.00315	CcSEcCtD
Metyrosine—Urticaria—Vinorelbine—lung cancer	0.00146	0.00312	CcSEcCtD
Metyrosine—Diarrhoea—Erlotinib—lung cancer	0.00146	0.00311	CcSEcCtD
Metyrosine—Abdominal pain—Vinorelbine—lung cancer	0.00146	0.00311	CcSEcCtD
Metyrosine—Oedema peripheral—Docetaxel—lung cancer	0.00146	0.00311	CcSEcCtD
Metyrosine—Thrombocytopenia—Gemcitabine—lung cancer	0.00145	0.00309	CcSEcCtD
Metyrosine—Anxiety—Cisplatin—lung cancer	0.00144	0.00306	CcSEcCtD
Metyrosine—Anaemia—Etoposide—lung cancer	0.00143	0.00306	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.00143	0.00283	CbGpPWpGaD
Metyrosine—Tremor—Paclitaxel—lung cancer	0.00142	0.00304	CcSEcCtD
Metyrosine—Vomiting—Vinblastine—lung cancer	0.00141	0.00301	CcSEcCtD
Metyrosine—Anaemia—Paclitaxel—lung cancer	0.0014	0.003	CcSEcCtD
Metyrosine—TH—Metabolism—HSD17B10—lung cancer	0.00139	0.00276	CbGpPWpGaD
Metyrosine—Headache—Vinblastine—lung cancer	0.00139	0.00297	CcSEcCtD
Metyrosine—Insomnia—Irinotecan—lung cancer	0.00138	0.00293	CcSEcCtD
Metyrosine—Vomiting—Topotecan—lung cancer	0.00137	0.00292	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—CASP3—lung cancer	0.00137	0.0027	CbGpPWpGaD
Metyrosine—Hypersensitivity—Vinorelbine—lung cancer	0.00136	0.0029	CcSEcCtD
Metyrosine—Vomiting—Erlotinib—lung cancer	0.00136	0.00289	CcSEcCtD
Metyrosine—Thrombocytopenia—Cisplatin—lung cancer	0.00135	0.00288	CcSEcCtD
Metyrosine—Headache—Topotecan—lung cancer	0.00135	0.00288	CcSEcCtD
Metyrosine—Insomnia—Gemcitabine—lung cancer	0.00134	0.00286	CcSEcCtD
Metyrosine—Headache—Erlotinib—lung cancer	0.00134	0.00285	CcSEcCtD
Metyrosine—Acetaminophen—ABCB1—lung cancer	0.00133	0.0506	CrCbGaD
Metyrosine—TH—SIDS Susceptibility Pathways—JUN—lung cancer	0.00133	0.00263	CbGpPWpGaD
Metyrosine—Asthenia—Vinorelbine—lung cancer	0.00132	0.00282	CcSEcCtD
Metyrosine—Eosinophilia—Methotrexate—lung cancer	0.00132	0.00281	CcSEcCtD
Metyrosine—Nausea—Vinblastine—lung cancer	0.00132	0.00281	CcSEcCtD
Metyrosine—Fatigue—Irinotecan—lung cancer	0.00131	0.0028	CcSEcCtD
Metyrosine—TH—Metabolism—CKB—lung cancer	0.0013	0.00257	CbGpPWpGaD
Metyrosine—Anxiety—Paclitaxel—lung cancer	0.00129	0.00275	CcSEcCtD
Metyrosine—Nausea—Topotecan—lung cancer	0.00128	0.00273	CcSEcCtD
Metyrosine—Fatigue—Gemcitabine—lung cancer	0.00128	0.00272	CcSEcCtD
Metyrosine—Confusional state—Etoposide—lung cancer	0.00128	0.00272	CcSEcCtD
Metyrosine—Nausea—Erlotinib—lung cancer	0.00127	0.0027	CcSEcCtD
Metyrosine—Dry mouth—Paclitaxel—lung cancer	0.00127	0.0027	CcSEcCtD
Metyrosine—Diarrhoea—Vinorelbine—lung cancer	0.00126	0.00269	CcSEcCtD
Metyrosine—Feeling abnormal—Irinotecan—lung cancer	0.00125	0.00267	CcSEcCtD
Metyrosine—Confusional state—Paclitaxel—lung cancer	0.00125	0.00267	CcSEcCtD
Metyrosine—Dysuria—Methotrexate—lung cancer	0.00125	0.00266	CcSEcCtD
Metyrosine—Gastrointestinal pain—Irinotecan—lung cancer	0.00124	0.00265	CcSEcCtD
Metyrosine—Thrombocytopenia—Etoposide—lung cancer	0.00124	0.00264	CcSEcCtD
Metyrosine—Erectile dysfunction—Methotrexate—lung cancer	0.00123	0.00262	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—EP300—lung cancer	0.00122	0.00242	CbGpPWpGaD
Metyrosine—Feeling abnormal—Gemcitabine—lung cancer	0.00122	0.0026	CcSEcCtD
Metyrosine—TH—Metabolism—GSTM2—lung cancer	0.00122	0.00241	CbGpPWpGaD
Metyrosine—TH—Metabolism—CNDP2—lung cancer	0.00122	0.00241	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Paclitaxel—lung cancer	0.00121	0.00259	CcSEcCtD
Metyrosine—Abdominal pain—Irinotecan—lung cancer	0.0012	0.00256	CcSEcCtD
Metyrosine—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.0012	0.00256	CcSEcCtD
Metyrosine—Anaemia—Docetaxel—lung cancer	0.00119	0.00254	CcSEcCtD
Metyrosine—TH—Metabolism—MTMR3—lung cancer	0.00119	0.00235	CbGpPWpGaD
Metyrosine—Vomiting—Vinorelbine—lung cancer	0.00117	0.0025	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.00116	0.0023	CbGpPWpGaD
Metyrosine—TH—Metabolism—PGAM1—lung cancer	0.00116	0.00229	CbGpPWpGaD
Metyrosine—Headache—Vinorelbine—lung cancer	0.00116	0.00246	CcSEcCtD
Metyrosine—Eosinophilia—Doxorubicin—lung cancer	0.00114	0.00244	CcSEcCtD
Metyrosine—Feeling abnormal—Cisplatin—lung cancer	0.00114	0.00243	CcSEcCtD
Metyrosine—Haematuria—Methotrexate—lung cancer	0.00113	0.00242	CcSEcCtD
Metyrosine—Insomnia—Paclitaxel—lung cancer	0.00112	0.00239	CcSEcCtD
Metyrosine—Hypersensitivity—Irinotecan—lung cancer	0.00112	0.00239	CcSEcCtD
Metyrosine—TH—Metabolism—CYP2A7—lung cancer	0.0011	0.00218	CbGpPWpGaD
Metyrosine—Nausea—Vinorelbine—lung cancer	0.0011	0.00234	CcSEcCtD
Metyrosine—Asthenia—Irinotecan—lung cancer	0.00109	0.00233	CcSEcCtD
Metyrosine—Fatigue—Etoposide—lung cancer	0.00109	0.00233	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—JUN—lung cancer	0.00108	0.00214	CbGpPWpGaD
Metyrosine—TH—Metabolism—SDC4—lung cancer	0.00108	0.00214	CbGpPWpGaD
Metyrosine—Dysuria—Doxorubicin—lung cancer	0.00108	0.0023	CcSEcCtD
Metyrosine—Dry mouth—Docetaxel—lung cancer	0.00107	0.00229	CcSEcCtD
Metyrosine—Fatigue—Paclitaxel—lung cancer	0.00107	0.00228	CcSEcCtD
Metyrosine—Asthenia—Gemcitabine—lung cancer	0.00106	0.00227	CcSEcCtD
Metyrosine—Confusional state—Docetaxel—lung cancer	0.00106	0.00226	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—PTEN—lung cancer	0.00105	0.00207	CbGpPWpGaD
Metyrosine—Feeling abnormal—Etoposide—lung cancer	0.00104	0.00222	CcSEcCtD
Metyrosine—Diarrhoea—Irinotecan—lung cancer	0.00104	0.00222	CcSEcCtD
Metyrosine—Gastrointestinal pain—Etoposide—lung cancer	0.00103	0.00221	CcSEcCtD
Metyrosine—Thrombocytopenia—Docetaxel—lung cancer	0.00103	0.0022	CcSEcCtD
Metyrosine—Feeling abnormal—Paclitaxel—lung cancer	0.00102	0.00218	CcSEcCtD
Metyrosine—Hypersensitivity—Cisplatin—lung cancer	0.00102	0.00217	CcSEcCtD
Metyrosine—Gastrointestinal pain—Paclitaxel—lung cancer	0.00101	0.00216	CcSEcCtD
Metyrosine—Diarrhoea—Gemcitabine—lung cancer	0.00101	0.00216	CcSEcCtD
Metyrosine—Urticaria—Etoposide—lung cancer	0.001	0.00214	CcSEcCtD
Metyrosine—Abdominal pain—Etoposide—lung cancer	0.001	0.00213	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—EP300—lung cancer	0.000999	0.00198	CbGpPWpGaD
Metyrosine—Asthenia—Cisplatin—lung cancer	0.000991	0.00211	CcSEcCtD
Metyrosine—Urticaria—Paclitaxel—lung cancer	0.000985	0.0021	CcSEcCtD
Metyrosine—TH—Metabolism—RRM1—lung cancer	0.000983	0.00195	CbGpPWpGaD
Metyrosine—TH—Metabolism—GSTA3—lung cancer	0.000983	0.00195	CbGpPWpGaD
Metyrosine—Haematuria—Doxorubicin—lung cancer	0.000981	0.00209	CcSEcCtD
Metyrosine—Abdominal pain—Paclitaxel—lung cancer	0.00098	0.00209	CcSEcCtD
Metyrosine—Vomiting—Irinotecan—lung cancer	0.000967	0.00206	CcSEcCtD
Metyrosine—Headache—Irinotecan—lung cancer	0.000953	0.00203	CcSEcCtD
Metyrosine—Insomnia—Docetaxel—lung cancer	0.000951	0.00203	CcSEcCtD
Metyrosine—Diarrhoea—Cisplatin—lung cancer	0.000945	0.00202	CcSEcCtD
Metyrosine—Vomiting—Gemcitabine—lung cancer	0.000942	0.00201	CcSEcCtD
Metyrosine—Hypersensitivity—Etoposide—lung cancer	0.000932	0.00199	CcSEcCtD
Metyrosine—Ibuprofen—PTGS2—lung cancer	0.000932	0.0353	CrCbGaD
Metyrosine—Headache—Gemcitabine—lung cancer	0.000928	0.00198	CcSEcCtD
Metyrosine—TH—Metabolism—B4GALT5—lung cancer	0.000924	0.00183	CbGpPWpGaD
Metyrosine—Hypersensitivity—Paclitaxel—lung cancer	0.000914	0.00195	CcSEcCtD
Metyrosine—Oedema peripheral—Doxorubicin—lung cancer	0.00091	0.00194	CcSEcCtD
Metyrosine—Asthenia—Etoposide—lung cancer	0.000908	0.00194	CcSEcCtD
Metyrosine—Fatigue—Docetaxel—lung cancer	0.000906	0.00193	CcSEcCtD
Metyrosine—Nausea—Irinotecan—lung cancer	0.000903	0.00193	CcSEcCtD
Metyrosine—TH—Metabolism—GSTA4—lung cancer	0.000899	0.00178	CbGpPWpGaD
Metyrosine—Asthenia—Paclitaxel—lung cancer	0.00089	0.0019	CcSEcCtD
Metyrosine—Nausea—Gemcitabine—lung cancer	0.00088	0.00188	CcSEcCtD
Metyrosine—Vomiting—Cisplatin—lung cancer	0.000878	0.00187	CcSEcCtD
Metyrosine—TH—Metabolism—GSTA2—lung cancer	0.000876	0.00173	CbGpPWpGaD
Metyrosine—Feeling abnormal—Docetaxel—lung cancer	0.000866	0.00185	CcSEcCtD
Metyrosine—Diarrhoea—Etoposide—lung cancer	0.000865	0.00185	CcSEcCtD
Metyrosine—Gastrointestinal pain—Docetaxel—lung cancer	0.00086	0.00183	CcSEcCtD
Metyrosine—Anaemia—Methotrexate—lung cancer	0.000858	0.00183	CcSEcCtD
Metyrosine—Diarrhoea—Paclitaxel—lung cancer	0.000849	0.00181	CcSEcCtD
Metyrosine—TH—Metabolism—GSTA1—lung cancer	0.000845	0.00167	CbGpPWpGaD
Metyrosine—TH—Metabolism—ABCC3—lung cancer	0.000836	0.00166	CbGpPWpGaD
Metyrosine—Abdominal pain—Docetaxel—lung cancer	0.000831	0.00177	CcSEcCtD
Metyrosine—Ibuprofen—ALB—lung cancer	0.00083	0.0315	CrCbGaD
Metyrosine—Nausea—Cisplatin—lung cancer	0.00082	0.00175	CcSEcCtD
Metyrosine—TH—Metabolism—AKR1C1—lung cancer	0.000809	0.0016	CbGpPWpGaD
Metyrosine—Vomiting—Etoposide—lung cancer	0.000804	0.00172	CcSEcCtD
Metyrosine—TH—SIDS Susceptibility Pathways—IL6—lung cancer	0.000801	0.00159	CbGpPWpGaD
Metyrosine—Headache—Etoposide—lung cancer	0.000792	0.00169	CcSEcCtD
Metyrosine—Ibuprofen—ABCB1—lung cancer	0.000792	0.03	CrCbGaD
Metyrosine—Vomiting—Paclitaxel—lung cancer	0.000789	0.00168	CcSEcCtD
Metyrosine—TH—Metabolism—UGT1A1—lung cancer	0.000786	0.00156	CbGpPWpGaD
Metyrosine—Headache—Paclitaxel—lung cancer	0.000777	0.00166	CcSEcCtD
Metyrosine—Hypersensitivity—Docetaxel—lung cancer	0.000774	0.00165	CcSEcCtD
Metyrosine—Confusional state—Methotrexate—lung cancer	0.000764	0.00163	CcSEcCtD
Metyrosine—TH—Metabolism—GNG11—lung cancer	0.000758	0.0015	CbGpPWpGaD
Metyrosine—Asthenia—Docetaxel—lung cancer	0.000754	0.00161	CcSEcCtD
Metyrosine—Nausea—Etoposide—lung cancer	0.000751	0.0016	CcSEcCtD
Metyrosine—Anaemia—Doxorubicin—lung cancer	0.000743	0.00159	CcSEcCtD
Metyrosine—Thrombocytopenia—Methotrexate—lung cancer	0.000742	0.00158	CcSEcCtD
Metyrosine—Nausea—Paclitaxel—lung cancer	0.000737	0.00157	CcSEcCtD
Metyrosine—TH—Metabolism—ALDOA—lung cancer	0.000721	0.00143	CbGpPWpGaD
Metyrosine—Diarrhoea—Docetaxel—lung cancer	0.000719	0.00153	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—TP53—lung cancer	0.000715	0.00142	CbGpPWpGaD
Metyrosine—TH—Metabolism—NCOA3—lung cancer	0.0007	0.00139	CbGpPWpGaD
Metyrosine—Insomnia—Methotrexate—lung cancer	0.000685	0.00146	CcSEcCtD
Metyrosine—Anxiety—Doxorubicin—lung cancer	0.000682	0.00145	CcSEcCtD
Metyrosine—TH—Metabolism—ABCG2—lung cancer	0.000681	0.00135	CbGpPWpGaD
Metyrosine—TH—Metabolism—ADCY1—lung cancer	0.000681	0.00135	CbGpPWpGaD
Metyrosine—Dry mouth—Doxorubicin—lung cancer	0.000669	0.00143	CcSEcCtD
Metyrosine—Vomiting—Docetaxel—lung cancer	0.000668	0.00143	CcSEcCtD
Metyrosine—TH—Metabolism—ENO2—lung cancer	0.000668	0.00132	CbGpPWpGaD
Metyrosine—TH—Metabolism—HPGDS—lung cancer	0.000668	0.00132	CbGpPWpGaD
Metyrosine—TH—Metabolism—PPP2R1B—lung cancer	0.000664	0.00131	CbGpPWpGaD
Metyrosine—Confusional state—Doxorubicin—lung cancer	0.000662	0.00141	CcSEcCtD
Metyrosine—Headache—Docetaxel—lung cancer	0.000659	0.0014	CcSEcCtD
Metyrosine—TH—Circadian rythm related genes—IL6—lung cancer	0.000654	0.0013	CbGpPWpGaD
Metyrosine—Fatigue—Methotrexate—lung cancer	0.000653	0.00139	CcSEcCtD
Metyrosine—TH—Metabolism—GSTT1—lung cancer	0.000648	0.00128	CbGpPWpGaD
Metyrosine—Thrombocytopenia—Doxorubicin—lung cancer	0.000642	0.00137	CcSEcCtD
Metyrosine—TH—Metabolism—GCLC—lung cancer	0.00064	0.00127	CbGpPWpGaD
Metyrosine—TH—Metabolism—CYP2A6—lung cancer	0.00064	0.00127	CbGpPWpGaD
Metyrosine—Nausea—Docetaxel—lung cancer	0.000624	0.00133	CcSEcCtD
Metyrosine—Feeling abnormal—Methotrexate—lung cancer	0.000624	0.00133	CcSEcCtD
Metyrosine—Gastrointestinal pain—Methotrexate—lung cancer	0.00062	0.00132	CcSEcCtD
Metyrosine—TH—Metabolism—ENO1—lung cancer	0.000607	0.0012	CbGpPWpGaD
Metyrosine—Urticaria—Methotrexate—lung cancer	0.000602	0.00128	CcSEcCtD
Metyrosine—Abdominal pain—Methotrexate—lung cancer	0.000599	0.00128	CcSEcCtD
Metyrosine—Insomnia—Doxorubicin—lung cancer	0.000593	0.00127	CcSEcCtD
Metyrosine—Fatigue—Doxorubicin—lung cancer	0.000566	0.00121	CcSEcCtD
Metyrosine—Hypersensitivity—Methotrexate—lung cancer	0.000558	0.00119	CcSEcCtD
Metyrosine—TH—Metabolism—CYP2E1—lung cancer	0.000545	0.00108	CbGpPWpGaD
Metyrosine—Asthenia—Methotrexate—lung cancer	0.000544	0.00116	CcSEcCtD
Metyrosine—Feeling abnormal—Doxorubicin—lung cancer	0.000541	0.00115	CcSEcCtD
Metyrosine—TH—Metabolism—NQO1—lung cancer	0.000538	0.00107	CbGpPWpGaD
Metyrosine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000536	0.00114	CcSEcCtD
Metyrosine—Urticaria—Doxorubicin—lung cancer	0.000521	0.00111	CcSEcCtD
Metyrosine—Abdominal pain—Doxorubicin—lung cancer	0.000519	0.00111	CcSEcCtD
Metyrosine—Diarrhoea—Methotrexate—lung cancer	0.000518	0.00111	CcSEcCtD
Metyrosine—TH—Metabolism—STK11—lung cancer	0.000485	0.000961	CbGpPWpGaD
Metyrosine—Hypersensitivity—Doxorubicin—lung cancer	0.000483	0.00103	CcSEcCtD
Metyrosine—Vomiting—Methotrexate—lung cancer	0.000482	0.00103	CcSEcCtD
Metyrosine—Headache—Methotrexate—lung cancer	0.000475	0.00101	CcSEcCtD
Metyrosine—Asthenia—Doxorubicin—lung cancer	0.000471	0.001	CcSEcCtD
Metyrosine—Nausea—Methotrexate—lung cancer	0.00045	0.00096	CcSEcCtD
Metyrosine—TH—Metabolism—GSTP1—lung cancer	0.000449	0.00089	CbGpPWpGaD
Metyrosine—Diarrhoea—Doxorubicin—lung cancer	0.000449	0.000958	CcSEcCtD
Metyrosine—TH—Metabolism—CAT—lung cancer	0.000437	0.000866	CbGpPWpGaD
Metyrosine—TH—Metabolism—ABCB1—lung cancer	0.000425	0.000842	CbGpPWpGaD
Metyrosine—TH—Metabolism—TYMS—lung cancer	0.000418	0.000827	CbGpPWpGaD
Metyrosine—Vomiting—Doxorubicin—lung cancer	0.000417	0.00089	CcSEcCtD
Metyrosine—TH—Metabolism—GSTM1—lung cancer	0.000413	0.000817	CbGpPWpGaD
Metyrosine—Headache—Doxorubicin—lung cancer	0.000411	0.000877	CcSEcCtD
Metyrosine—TH—Metabolism—CYP1A1—lung cancer	0.000391	0.000775	CbGpPWpGaD
Metyrosine—Nausea—Doxorubicin—lung cancer	0.00039	0.000831	CcSEcCtD
Metyrosine—TH—Metabolism—ERCC2—lung cancer	0.000388	0.000769	CbGpPWpGaD
Metyrosine—TH—Metabolism—APOA1—lung cancer	0.000336	0.000665	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CG—lung cancer	0.000306	0.000607	CbGpPWpGaD
Metyrosine—TH—Metabolism—POMC—lung cancer	0.000292	0.000578	CbGpPWpGaD
Metyrosine—TH—Metabolism—CREBBP—lung cancer	0.000284	0.000563	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CD—lung cancer	0.000269	0.000534	CbGpPWpGaD
Metyrosine—TH—Metabolism—ALB—lung cancer	0.000266	0.000527	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CB—lung cancer	0.000235	0.000465	CbGpPWpGaD
Metyrosine—TH—Metabolism—PTGS2—lung cancer	0.000233	0.000461	CbGpPWpGaD
Metyrosine—TH—Metabolism—PTEN—lung cancer	0.000203	0.000402	CbGpPWpGaD
Metyrosine—TH—Metabolism—EP300—lung cancer	0.000194	0.000383	CbGpPWpGaD
Metyrosine—TH—Metabolism—PIK3CA—lung cancer	0.000143	0.000284	CbGpPWpGaD
Metyrosine—TH—Metabolism—AKT1—lung cancer	0.000117	0.000232	CbGpPWpGaD
